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1 Introduction
In 1927, HOFBAUER AND HOERNER [11] used pos-
terior pituitary extracts to induce labor. Since
then, oxytocin has been synthetically prepared
and widely used for both induction and augmenta-
tion of labor [3]. More recently oxytocin has been
employed for the oxytocin challenge test to evalu-
ate fetal heart response to the stress of uterine
contractions. Oxytocin has been given transbu-
cally, intramuscularly or intravenously but in all
its uses, it is generally given intravenously through
a continuous infusion. The transbuccal route has
been largely abandoned and the intramuscular
route is only used in veterinary practice [3]. With
careful intrauterine pressure monitoring and con-
tinuous fetal heart rate surveillance, oxytocin is
quite safe and well accepted but there are several
side effects, all of which appear to be dose-depen-
dent.
Since oxytocin is secreted episodically in spurts or
pulses [7] and myometrial oxytocin receptor sites
while occupied are unavailable, continuous intra-
venous infusion of oxytocin does not appear to
be consistent with physiological principles of en-
dogenous oxytocin release in vivo. Administration
of oxytocin in pulsatile boluses is more consistent
with the physiologic release of this neurohypophy-
seal hormone and its effect on the myometrium.
The total dose of oxytocin required could be re-
duced. In a preliminary study, PAVLOU et al. [12]
obtained encouraging results which showed that
pulsed administration of oxytocin was just as ef-
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fective as continuous intravenous infusion for in-
duction of labor. A prospective, randomized study
was initiated to compare the efficacy and safety
of pulsed administration of oxytocin with the tra-
ditional continuous intravenous infusion method
for induction of labor. This paper reports our
findings of such a study.
2 Materials and methods
2.1 Patient selection
Twenty pregnant patients in the third trimester
with medical indications for induction of labor
and who signed an informed consent were selected
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for this prospective randomized study, which was
aprroved by our Institutional Review Board. The
decision to induce labor was made by the obstetri-
cal staff managing the patient and did not involve
the study investigators. Women with a previous
uterine scar, a non-cephalic fetal presentation or a
clinically contracted pelvis were excluded. Patients
were randomized into the treatment group by their
medical record number. A pelvic examination was
performed to assess the Bishop score [1]. One of
us (RRO) examined all the patients for the Bishop
score, monitored them throughout their induction
and was with them throughout their oxytocin
administration. Once the cervix was 2 centimeters
dilated, amniotomy was performed. All patients
were monitored continuously for uterine contrac-
tions and fetal heart by external methods and
after amniotomy, with internal uterine pressure
catheter and fetal scalp electrode. The fetal moni-
toring and uterine pressure tracings throughout
the induction until delivery were reviewed. Ten
patients received oxytocin by pulsatile intravenous
administration while the other 10 received oxyto-
cin by continuous intravenous infusion.
2.2 Adminstration of oxytocin
Oxytocin was delivered in pulsatile boluses every
8 minutes via an intermittent infusion pump
model As-2C (Autosyringe, Hooksett, New
Hampshire). Each bolus was delivered over a ten-
second period. The oxytocin was made up in 2
different concentrations (10 Units of oxytocin in
100 ml of normal saline or 40 Units of oxytocin
in 50 ml of normal saline) to provide a wide range
of dose per pulse as well as ease of administration.
Pulsed administration of oxytocin was initially
started at 1 mU/pulse every 8 minutes with the
pulsed dose doubled every 24 minutes (interval of
3 pulses of the same dose) until the patient was in
adequate labor which is establishment of regular
contractions equal to or greater than 160 Montevi-
deo units. When the pulsed dose reached 32 mU/
pulse, the higher concentration of oxytocin solu-
tion (40 Units in 50 ml of normal saline) was used.
The control group received continuous intrave-
nous infusion of oxytocin administered by an
IMED 927 pump (Imed Corporation, San Diego,
California). Oxytocin infusion was started at
1 mU/minute and doubled every 30 minutes until
8mU/minute, after which it was increased by
4 mU/minute every 30 minutes until uterine con-
tractions similar to that described for the pulsed
oxytocin group were established.
The clinical management of the two groups was
similar with respect to volume of fluids adminis-
tered, monitoring techniques and care by the same
team of labor and delivery physicians with one of
us (PRO) present throughout the induction. The
patients in the two groups were subsequently com-
pared and analyzed for their obstetrical histories,
labor and delivery outcome, neonate profile and
oxytocin data.
2.3 Statistical analysis
The means ± stardard error of the means were
analyzed for differences using the non-paried stu-
dents' t test, chi-square analysis and one-way
analysis of variance. Two-tailed p values were
employed and values greater than 0.05 were con-
sidered not dignificant.
3 Results
The patient profiles in the pulsed and control
groups are summarized in table I. There were no
significant differences between the two groups.
Both groups had many obese individuals. Bishop
scores of the cervix were similar in both groups. In
the pulsed oxytocin group, 2 patients had Bishop
scores of 4 or less while 8 had Bishop scores of
more than 4. In the continuous group, 3 patients
had Bishop scores of 4 or less while 7 had Bishop
scores of more than 4.
Table II summarizes the events during labor and
delivery. The time intervals were calculated from
the onset of oxytocin administration. The cesarean
section rates were high in both groups. In each
group there was a cesarean section performed for
fetal distress and one for uterine hypotonia. Two
patients in the pulsed group and 3 patients in the
continuous group were delivered abdominally for
failure to progress. These patients failed to pro-
gress at the same cervical dilatation (5 cm or more)
with no further descent of the presenting part for
more than 3 hours. Of these 5 patients, 2 (one
from each treatment group) had large babies (4220
and 4530 grams), one had chorioamnionitis and
2 (one from each treatment group) which had
been at 6 — 7 cm dilatation for a prolonged time
had babies weighing 3620 and 3390 grams. Primi-
gravid patients had a higher cesarean section rate,
but the number of patients is not large enough
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Table I. Clinical profile of patients undergoing induction of labor with either pulsed or continuous intravenous
administration of oxytocin.
Maternal characteristics
Age (years)
Parity
Gestation (days)
Maternal weight (kg)
Bishops score
Pulsed
oxytocin group
n = 10
23.5 + 1.8*
(17-30) t
0.8 + 0.3
(0-3)
285 ± 7.2
(261-301)
95.2 + 5.0
(78-113)
7.3 + 0.7
(4-10)
Continuous
oxytocin group
n = 10
25.2 + 2.0
(18-38)
1.0 + 0.6
(0-5)
283 ± 5.8
(251-301)
97.1 + 7.3
(73-128)
5.9 + 0.9
(1-11)
Differences between
pulsed and continuous
oxytocin groups
ns
ns
ns
ns
ns
ns = not significant
* = mean ± S. E. M.
t = number in brackets indicate the range.
Table Π. Labor and delivery data (mean ± S. E. M.) of patients who had induced labor with either pulsed or
continuous intravenous administration of oxytocin.
Time till adequate labor (min)*
Induction-delivery internal (min)
Incidence of hyperstimulation**
Vaginal delivery rate
Change in Hgb (g/dl)
Pain medications needed
Pulsed
oxytocin group
(n = 10)
241 + 34
(120 -424) t
648 + 127
(82-1102)
10%
60%
1.3 ± 0.3
(0.4-3.0)
60%
Continuous
oxytocin group
(n = 10)
270 + 51
(70-505)
812 + 95
(190-1173)
60%
50%
1.5 ± 0.27
(0.3-2.7)
70%
Differences between
pulsed and continuous
oxytocin groups
ns
ns
ns
ns
ns
ns
* Adequate labor = regular uterine contractions > 160 Montevideo units.
** Hyperstimulation defined as increased basal tone or frequency of uterine contraction that requires stopping
oxytocin.
t Number in brackets indicate the range.
for statistical evaluation. Three out of 4 primigra-
vidas in the control group and all 4 primigravidas
in the pulsed group were delivered by cesarean
section.
Table III summarizes the profile of the neonates.
The mean birth weight was significantly higher in
the pulsed oxytocin group (p = <0.05).
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Table ΙΠ. Profile of neonates born to mothers who underwent induction of labor with pulsed or continuous
intravenous administration of oxytocin.
Profile of neonate
Sex (females)
Weight (g)
Apgar score
1 minute
5 minutes
Pulsed
oxytocin group
(n = 10)
30%
3876 + 162
(3065 -4530) f
6.8 + 0.6
(4-0)
8.6 + 0.17
(8-9)
Continuous Differences between
oxytocin group pulsed and continuous
(n = 10) oxytocin groups
60% ns
3255 + 251 p = <0.05*
(1720-4220)
7.7 + 0.3 ns
(6-9)
8.7 + 0.3 ns
(7-9)
ns = not significant
* = significant
t = number in brackets indicate range
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Figure 1. Mean + SEM (standard error of the mean)
dose of oxytocin required for induction of labor with
pulsed or continuous intravenous infusion of oxytocin.
Pulsatile administration of oxytocin required less total
dose of oxytocin and a significantly lower peak oxytocin
infusion rate than continuous intravenous infusion (p =
<0.05).
The amounts of oxytocin administered are shown
in figure 1. With continuous oxytocin administra-
tion, the patients required 71% more oxytocin
than with pulsed administration. When the highest
dose of oxytocin used in each patient was calcu-
lated and transformed to mU/min, the pulsed
oxytocin group received a significantly lower peak
dose of oxytocin (5.2 ± 0.8) than the continuous
oxytocin group (9.2 ± 1.8, p = <0.05).
4 Comments
The present pilot study of a limited number of
patients shows that pulsed oxytocin infusion is
as effective and safe as continuous intravenous
infusion of oxytocin for induction of labor but
has the additional advantage of requiring much
less oxytocin. Our findings support an earlier re-
port demonstrating the efficacy of pulsed oxytocin
infusion combined with amniotomy for induction
of labor [12]. However, we have simplified our
protocol in the present study where the oxytocin
is given long before amniotomy and in the pre-
sence of a low Bishop score. Thus, induction of
uterine contractions and subsequent establish-
ment of labor can be readily and safely achieved
with lower doses of oxytocin using pulsatile infu-
sion of oxytocin.
Oxytocin is secreted episodically in spurts or
pulses during pregnancy and labor in women [7,
10]. DAWOOD et al. [7] have shown that in normal
human parturition, 2 to 3 pulses of oxytocin are
released every 10 minutes. Most peptide hormones
and even fetoplacental steroid hormones are in-
creasingly shown to be secreted episodically.
Specific receptors for oxytocin are present in the
uterine smooth muscle and the occupied receptors
become temporarily unavailable to the infused or
circulating oxytocin for binding. The duration of
the oxytocin-receptor binding or receptor occupa-
tion is not known. Thus continuous intravenous
infusion of oxytocin is inconsistent with our
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understanding of oxytocin secretion and our cur-
rent concept of peptide hormone-receptor bind-
ing. Pulsatile administration of oxytocin mimicks
episodic release of oxytocin during labor and
could avoid continuous flooding of the uterus and
saturation of unavailable, occupied receptor sites.
We have chosen an oxytocin pulse frequency of
every eight minutes for convenience of adjusting
the autosyringe pump and to balance between the
frequency of oxytocin spurts seen during normal
labor and the half-life of oxytocin. The half-life
of oxytocin is 10 minutes [8] and the metabolic
clearance rate is similar in the pregnant and non-
pregnant states [4]. It is noteworthy that the
highest dose of oxytocin infused per minute (ex-
pressed for comparison purposes) was signifi-
cantly lower with pulsatile administration than
with continuous infusion (figure 1). In this respect,
it is striking that the mean maximum dose of
oxytocin required by pulsatile infusion was 5.2
mU/min, a rate which is similar to human fetal
oxytocin infusion of 3.0 mU/min towards the ma-
ternal compartment via the umbilical cord during
spontaneous labor [4, 6]. The maximum dose of
oxytocin per minute required for pulsatile admin-
istration is also consistent with the physiolgoical
dose of oxytocin so strongly advocated by some
[14]. Furthermore, the lower dose of oxytocin
and its pulsatile delivery are probably significant
factors in the lower incidence of uterine hypersti-
mulation compared to continuous oxytocin infu-
sion.
The total dose of oxytocin required for pulsed
administration to induce adequate uterine con-
tractions and establish labor was much smaller
than that needed for continuous infusion. Such a
reduction can be clinically important towards the
likelihood of developing neonatal hyperbilirubine-
mia. The pathogenesis of oxytocin-induced neon-
atal hyperbilirubinemia is due to increased os-
motic fragility of the erythrocytes and transpla-
cental hyponatremia both of which are time-re-
lated and dose-dependent on oxytocin [2, 13]. A
highly significant correlation between cord biUni-
bin levels and the total amount of oxytocin given
to the mother to induce labor has been reported
[9], with increased neonatal hyperbilirubinemia
found when mothers were given a mean total
oxytocin dose of 4500 mil or more [2]. Thus,
pulsed administration with a mean total oxytocin
dose of 2454 mil is less likely to give rise to
oxytocin-induced neonatal hyperbilirubinemia
than continuous intravenous infusion of oxytocin.
With a trend towards less hyperstimulation with
pulsatile administration, this method of giving
oxytocin offers an advantage over continuous ad-
ministration. The reduced occurrence of uterine
hyperstimulation with the pulsatile administration
is likely to be due to the lower dose of oxytocin
required since we have previously established that
the uterine activity can be correlated to the ma-
ternal plasma oxytocin levels attained when oxyto-
cin was infused into the mother [5].
There is also the added advantage of reduced cost
with pulsatile administration of oxytocin. We have
calculated that the average cost of medication and
supplies in our institution for pulsatile administra-
tion of oxytocin is $66 versus $102 for continuous
infusion.
The cesarean section rates for both methods of
giving oxytocin were higher than our overall cesar-
ean section of 22.4% for the same period of time.
This is not altogether unexpected as the patients
recruited into the study were undergoing induc-
tion of labor for significant medical reasons and
were therefore at high risk for abdominal delivery.
Inspite of the pulsatile oxytocin group having a
significantly higher mean infant birth weight, the
cesarean section rate was similar to that for the
continuous oxytocin infusion group. The differen-
ces in the mean birth weight between the two
groups were unlikely to have affected the differen-
ces observed in their response to their respective
methods of induction in favor of the pulsed oxyto-
cin group. Indeed if there were to be an effect,
the significantly higher birth weight in the pulsed
oxytocin group would have a less favorable effect
on the response to induction. However, inspite of
the larger birth weights, the pulsed oxytocin group
gave more favorable results.
Overall, the findings in this prospective, rando-
mized study of a limited number of patients indi-
cate that pulsatile administration of oxytocin ap-
pears to be as effective as the conventional con-
tinuous intravenous infusion for induction of la-
bor. Pulsatile administration of oxytocin is as safe
and perhaps safer than continuous oxytocin infu-
sion, with reduced incidence of uterine hypersti-
mulation, reduced total dose and infusion rate of
oxytocin and reduced cost. Pulsatile administra-
tion of oxytocin is more consistent with physio-
logical principles of the secretion of this neurohy-
pophysial hormone.
Further studies on a larger number of patients
should be a worthwhile endeavour.
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Summary
In a prospective randomized study, 20 patients with
term pregnancies underwent induction of labor with
either continuous or pulsed (every 8 minutes) intrave-
nous oxytocin infusion. There were no significant differ-
ences with respect to induction-labor interval, induction-
delivery interval, cesarean section rates, need for pain
relief and Apgar scores. Sixty percent of patients receiv-
ing continuous oxytocin infusion developed uterine hy-
perstimulation but only 10% receiving pulsed oxytocin
did so. However, the difference was not significant.
The mean + SEM total amount of oxytocin given by
continuous infusion was 4237 ± 1066 mU which was
70% more than by pulsatile infusion (2454 ± 808 mU),
The highest rate of oxytocin infused was significantly
lower by pulsatile administration (5.2 ± 0.8 mU/min)
than by continuous infusion (9.2 + 1.8 mU/min,
p = <0.05).
Our study demonstrates that pulsed administration of
oxytocin every 8 minutes is as effective and safe as
continuous intravenous infusion of oxytocin for induc-
tion of labor, requires less oxytocin with therefore, a
wider margin of safety and is consistent with the pulsatile
release of oxytocin during normal labor.
Keywords: Induction of labor, oxytocin, pulsatile oxytocin.
Zusammenfassung
Intermittierende Gabe von Oxytozin zur Einleitung der
Wehen: eine randomisierte kontrollierte Studie
In einer randomisierten prospektiven Studie unterzogen
sich 20 Patientinnen mit ausgetragenen Schwangerschaf-
ten einer Weheneinleitung entweder mit kontinuier-
licher oder pulsatiler (alle 8 Minuten) i. v. Infusion von
Oxytozin. Es gab keine nennenswerten Unterschiede,
weder hinsichtlich des Einleitungs-Wehenintervalls, des
Einleitungs-Geburtsintervalls, der Frequenz an Kaiser-
schnitten und des Bedarfs an Schmerzmitteln noch des
Apgar-Schemas. 60% der Patientinnen, die eine
Dauerinfusion erhalten hatten, zeigten eine uterine Hy-
perstimulation, welche aber nur zu 10% bei Frauen mit
einer intermittierten Infusion auftrat. Nichtsdestoweni-
ger war der Unterschied nicht signifikant. Die mittlere
Gesamtkonzentration + SEM, von Oxytozin mittels
Dauerinfusion war 4237 ± 1066 mU. Dies war 70%
mehr als mit intermittierender Infusion (2454 ± 808
mU). Die höchste Dosis an infundiertem Oxytozin war
bei der intermittierenden Methode (5,2 + 0,8 mU/min)
deutlich niedriger als bei der Dauerinfusion (9,2 ±1,8
mU/min, p = <0.05).
Unsere Studie zeigt, daß die intermittierende Gabe von
Oxytozin alle 8 Minuten genauso effektiv und sicher ist
wie die Dauerinfusion von Oxytozin zur Weheneinlei-
tung, daß aber weniger Oxytozin gebraucht wird und
damit ein größerer Sicherheitsbereich gegeben ist.
Außerdem stimmt diese Applikationsart mit der inter-
mittierten Freigabe von Oxytozin während nicht medi-
kamentös induzierter Wehen überein.
Schlüsselwörter: Einleitung von Wehen, Oxytozin, pulsatile Oxytozingabe.
Resume
Declenchement du travail par ocytocine pulsatile: etude
randomisee prospective et controlee
Dans une etude randomisee prospective, 20 patients ä
terme ont eu un declenchement de Faccouchement soit
par une perfusion continue d'ocytocine soit par une
perfusion pulsatile (toutes les 8 minutes). II n'y a pas eu
de difference significative en ce qui concerne Fintervalle
induction-travail, Fintervalle induction-accouchement,
le taux de cesarienne, la necessite de soulager la douleur
ni les scores d'Apgar. Soixante pour cent des patientes
ayant une perfusion continue d'ocytocine ont presente
une hyperstimulation mais^ seulement 10% de celles
ayant eu une perfusion pulsatile. Toutefois la difference
n'est pas significative. La quantite moyenne totale d'ocy-
tocine utilisee par perfusion continue a ete de 4237 +
1066 mU, ce qui est 70% en plus que pour les perfusions
pulsatiles (2454 ± 808 mU). Le rythme le plus eleve
d'administration d'ocytocine est signiflcativement infe-
rieur pour les perfusions pulsatiles (5,2 + 0,8 mU/min)
que pour les perfusions continues (9,2 ±1,8 mU/min,
p < 0,05).
Notre etude demontre que Fadministration pulsatile d'o-
cytocine toutes les 8 minutes est aussi efficace et aussi
sure que la perfusion continue d'ocytocine en intra-
veineux pour declencher le travail qu'elle necellite moins
d'ocytocine avec cependant une marge de surete plus
large et qu'elle est dans la logique de la liberation pulsa-
tile d'ocytocine au cours du travail normal.
Mots-cles: Declenchement du travail, ocytocine, ocytocine pulsatile.
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